期刊文献+

经皮剑突下心包穿刺技术的应用进展

Application Progress of Percutaneous Subxiphoid Pericardiocentesis
下载PDF
导出
摘要 心脏周围的心包形成了一个特有的腔隙,为心血管疾病的药物、生物等治疗措施提供了场所。然而,心包穿刺介入路径的选择对于心包内治疗的效果具有重要影响。目前,经皮剑突下的心包介入作为诸多途径之一,以其微创、并发症少的特点受到广泛关注,并在各种影像学辅助下被广泛用于心包内的治疗研究,如药物靶向输注、心外膜消融与起搏、干细胞等生物治疗均已与剑突下心包穿刺相结合。明确不同心包穿刺方式的优劣、辅助影像学手段及并发症,可促进经皮剑突下心包穿刺技术在心血管疾病治疗中的广泛应用。 The pericardium surrounding the heart forms a characteristic cavity that provides a site for pharmacologic,biological,and other therapeutic measures for cardiovascular diseases.However,the choice of route for pericardiocentesis intervention has a significant impact on the outcome of intrapericardial therapy.At present,percutaneous subxiphoid pericardiocentesis,as one of the many routes,has received widespread attention for its minimally invasive and less complication characteristics,and has been widely used in intrapericardial therapeutic studies with various imaging aides,such as drug-targeted infusion,epicardial ablation and pacing,stem cell therapy and other biological therapies,which all have been used in combination with subxiphoid pericardiocentesis for research or treatment.Clarifying the advantages and disadvantages of different pericardiocentesis methods,the auxiliary imaging methods and complications can promote the wide application of percutaneous pericardiocentesis in the treatment of cardiovascular diseases.
作者 李国强 周芳 王晞 王龙 LI Guoqiang;ZHOU Fang;WANG Xi;WANG Long(Department of Anesthesiology,Renmin Hospital of Wuhan University,Wuhan 430000,China;Department of Cardiology,Renmin Hospital of Wuhan University,Wuhan 430000,China;Cardiovascular Disease Institute,Wuhan University,Wuhan 430000,China)
出处 《医学综述》 CAS 2023年第21期4581-4587,共7页 Medical Recapitulate
基金 国家自然科学基金(81772044) 湖北省重点实验室开放项目(2021KFY035)。
关键词 心包穿刺术 剑突下 心血管疾病 微创技术 Pericardiocentesis Subxiphoid Cardiovascular disease Minimally invasive technology
  • 相关文献

参考文献3

二级参考文献11

  • 1Ellis SG, Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation, 1994, 90 (6) : 2725- 2730.
  • 2ShimonyA, Joseph L, Mottillo S, et al. Coronary artery perforation during percutaneous coronary intervention : a systematic review and meta-analysis. Can J Cardiol, 2011, 27 (6) :843-850.
  • 3Chua SK,Lee SH, Shyu KG, et al. Incidence, Management, and Clinical Outcomes of Procedure-Related Coronary Artery Perforation : Analysis of 13, 888 Coronary Angioplasty Procedures. Acta Cardiologica Sinica, 2008, 24(2) :80-85.
  • 4Holmes DR Jr, Nishimura R, Fountain R, et al. Latrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv, 2009, 2 (8) :705-717.
  • 5Hasan AG, Dolunay O, SerkanA, et al. Management of cardiac tamponade : a comperative study between echo-guided pericardiocentesis and surgery-a report of 100 patients. Cardiol Res Prac, 2011, 1978(38) :406-412.
  • 6Ioannis AS, Konstantinos K, Kirk NG. Delayed perforation after pereutaneous coronary intervention: rare and potentially lethal. Catheter Cardiovase Interv, 2014, 83 ( 1 ) :FA5-E50.
  • 7Wang X, Ge J. Balloon occlusion types in the treatment of eoronary perforation during pereutaneous coronary intervention. Cardiol Res Prae, 2014, 7840 ( 18 ) : 1155-1160.
  • 8Kumar R, Sinha A, Lin M J, et al. Complications of perieardioeentesis: A elinieal synopsis. Int J Crit Illn Inj Sei, 2015, 5(3) : 206-212.
  • 9Lee JK,Tsui KL, Chan KK, et al. Intra-perieardial thrombin injeetion for post-infaretion left ventrieular free wall rupture. Eur Heart J Acute Cardiovase Care, 2012, 1 (4) :337-340.
  • 10贺熙,毕学苑,王皓,于晓江,臧伟进.心血管缺血再灌注损伤钙调控的研究进展[J].生理学报,2012,64(3):321-326. 被引量:12

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部